A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer

PURPOSE: Ovarian cancer, like most solid tumors, is in dire need of effective therapies. The significance of this trial lies in its promise to spearhead the development of combination immunotherapy and to introduce novel approaches to therapeutic immunomodulation, which could enable otherwise ineffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandalaft, Lana E, Chiang, Cheryl L, Tanyi, Janos, Motz, Greg, Balint, Klara, Mick, Rosemarie, Coukos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693890/
https://www.ncbi.nlm.nih.gov/pubmed/23777306
http://dx.doi.org/10.1186/1479-5876-11-149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693890/
https://www.ncbi.nlm.nih.gov/pubmed/23777306
http://dx.doi.org/10.1186/1479-5876-11-149

Ejemplares similares